InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:InteRNA Technologies BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013989
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing miRNA-based therapeutics which controls genes connected in signal transduction pathways. InteRNA’s technologies comprise deep sequencing and bioinformatics, miRNA expression database, data analyses platform, and lentiviral-based miRNA overexpression library. The company specializes in oncology programs including in vivo proof of concept for non-formulated anti-miRNA mimics, demonstrating significant tumor suppression in a mouse tumor xenograft model and development of a miRNA compound for mutant B-Raf associated solid tumors. InteRNA is headquartered in Nijmegen, the Netherlands.

InteRNA Technologies BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
InteRNA Technologies BV, Medical Devices Deals, 2011 to YTD 2017 9
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
InteRNA Technologies Raises Additional Funds in Series A Financing 11
InteRNA Technologies Raises Funds Through Venture Financing 12
Partnerships 13
InteRNA Technologies Enters into Agreement with Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung 13
Silence Therapeutics Enters Into Co-Development Agreement With InteRNA Technologies 14
InteRNA Technologies BV – Key Competitors 15
InteRNA Technologies BV – Key Employees 16
InteRNA Technologies BV – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Key Facts 2
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
InteRNA Technologies BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
InteRNA Technologies BV, Deals By Therapy Area, 2011 to YTD 2017 8
InteRNA Technologies BV, Medical Devices Deals, 2011 to YTD 2017 9
InteRNA Technologies BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
InteRNA Technologies Raises Additional Funds in Series A Financing 11
InteRNA Technologies Raises Funds Through Venture Financing 12
InteRNA Technologies Enters into Agreement with Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung 13
Silence Therapeutics Enters Into Co-Development Agreement With InteRNA Technologies 14
InteRNA Technologies BV, Key Competitors 15
InteRNA Technologies BV, Key Employees 16
InteRNA Technologies BV, Other Locations 17

★海外企業調査レポート[InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Solent NHS Trust:企業の戦略的SWOT分析
    Solent NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Modec Inc (6269):企業の財務・戦略的SWOT分析
    Modec Inc (6269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AusTex Oil Ltd:企業の戦略的SWOT分析
    AusTex Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • La-Z-Boy Inc (LZB):企業の財務・戦略的SWOT分析
    La-Z-Boy Inc (LZB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Precision System Science Co Ltd (7707)-医療機器分野:企業M&A・提携分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company’s products include automated nucleic acid isolation system, large sample volume nucleic acid extraction sy …
  • Encore Capital Group Inc:企業のM&A・事業提携・投資動向
    Encore Capital Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Encore Capital Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Owensboro Municipal Utilities:企業の戦略的SWOT分析
    Owensboro Municipal Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • RPS Group Plc (RPS):石油・ガス:M&Aディール及び事業提携情報
    Summary RPS Group Plc (RPS Group) is an international consulting company. It provides advisory services related to the planning and development of energy and urban infrastructure, development and management of built and natural environment, and exploration and production of oil and gas and other nat …
  • CMS Energy Corporation (CMS):電力:M&Aディール及び事業提携情報
    Summary CMS Energy Corporation (CMS Energy) is an energy utility which provides electricity, natural gas, and banking services. It generates, procures, transmits, distributes, and sells energy. The company produces power from coal, oil and gas, hydro, wind, and solar sources. CMS Energy purchases, t …
  • Centrica Plc (CNA):企業の財務・戦略的SWOT分析
    Centrica Plc (CNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • SeraCare Life Sciences, Inc.-医療機器分野:企業M&A・提携分析
    Summary SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products i …
  • Globe Telecom, Inc.:企業の戦略・SWOT・財務分析
    Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PVA TePla AG (TPE):企業の財務・戦略的SWOT分析
    PVA TePla AG (TPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • RadNet Inc (RDNT)-医療機器分野:企業M&A・提携分析
    Summary RadNet Inc (RadNet) is a radiology company which specializes in diagnostic imaging services. The company offers freestanding, fixed-site diagnostic imaging services including imaging procedures magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nu …
  • The Scripps Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institut …
  • Nissin Electric Co Ltd (6641):企業の財務・戦略的SWOT分析
    Nissin Electric Co Ltd (6641) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Rohol-Aufsuchungs Aktiengesellschaft:石油・ガス:M&Aディール及び事業提携情報
    Summary Rohol-Aufsuchungs Aktiengesellschaft (RAG) is an oil and gas company. The company operates in oil and gas exploration, production and trading; and gas storage. It produces crude oil and natural gas. RAG offers services such as renewable energy projects development and crude oil stockpiling a …
  • Sumitomo Chemical Co., Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Electromagnetic Geoservices ASA (EMGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆